Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sight Sciences (SGHT) Accumulated Expenses (2020 - 2026)

Sight Sciences has reported Accumulated Expenses over the past 6 years, most recently at $6.1 million for Q4 2025.

  • For Q4 2025, Accumulated Expenses fell 37.25% year-over-year to $6.1 million; the TTM value through Dec 2025 reached $6.1 million, down 37.25%, while the annual FY2025 figure was $6.1 million, 37.25% down from the prior year.
  • Accumulated Expenses for Q4 2025 was $6.1 million at Sight Sciences, down from $6.2 million in the prior quarter.
  • Over five years, Accumulated Expenses peaked at $9.7 million in Q4 2024 and troughed at $266000.0 in Q2 2022.
  • A 5-year average of $4.8 million and a median of $5.1 million in 2025 define the central range for Accumulated Expenses.
  • Biggest five-year swings in Accumulated Expenses: tumbled 93.49% in 2022 and later soared 1346.11% in 2024.
  • Year by year, Accumulated Expenses stood at $6.0 million in 2021, then rose by 22.8% to $7.4 million in 2022, then tumbled by 38.41% to $4.5 million in 2023, then soared by 113.78% to $9.7 million in 2024, then plummeted by 37.25% to $6.1 million in 2025.
  • Business Quant data shows Accumulated Expenses for SGHT at $6.1 million in Q4 2025, $6.2 million in Q3 2025, and $5.2 million in Q2 2025.